Correlation Between Hookipa Pharma and Nkarta
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Nkarta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Nkarta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Nkarta Inc, you can compare the effects of market volatilities on Hookipa Pharma and Nkarta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Nkarta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Nkarta.
Diversification Opportunities for Hookipa Pharma and Nkarta
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Hookipa and Nkarta is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Nkarta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nkarta Inc and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Nkarta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nkarta Inc has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Nkarta go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Nkarta
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Nkarta. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.5 times less risky than Nkarta. The stock trades about -0.03 of its potential returns per unit of risk. The Nkarta Inc is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 815.00 in Nkarta Inc on August 24, 2024 and sell it today you would lose (570.00) from holding Nkarta Inc or give up 69.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 99.8% |
Values | Daily Returns |
Hookipa Pharma vs. Nkarta Inc
Performance |
Timeline |
Hookipa Pharma |
Nkarta Inc |
Hookipa Pharma and Nkarta Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Nkarta
The main advantage of trading using opposite Hookipa Pharma and Nkarta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Nkarta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nkarta will offset losses from the drop in Nkarta's long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Nkarta vs. Lyra Therapeutics | Nkarta vs. Hookipa Pharma | Nkarta vs. Cingulate Warrants | Nkarta vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |